Document Detail


How many potential drug-drug interactions cause adverse drug reactions in hospitalized patients?
MedLine Citation:
PMID:  23041466     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Potential drug-drug interactions (DDIs) are frequent in drug prescription but clinically significant are the ones which can result in changes of therapeutic effect of one of the two drugs or in adverse drug reactions (ADRs). The aim of this study was to assess the potential DDIs as well as the DDIs which cause adverse drug reactions (ADRs) in an internal medicine department hospitalized patients. METHODS: The prospective study included all patients admitted between November 2010 and January 2011 in an internal medicine ward. Information on patients' demographics and their medication use history was obtained from each patient by interview. In addition, medical history, medication use during hospitalization, and relevant laboratory and clinical data were obtained from medical records. Potential DDIs were identified using the Thomson Micromedex program. Each patient was monitored during the hospitalization period in order to detect the ADRs resulting from DDI's if present. RESULTS: Three hundred and five patients were enrolled in this study during 3months. Of 1279 potential DDIs, Fourteen led to 13 ADRs out of which 8 were serious and caused hospital admission or prolongation of hospitalization. There was a statistically significant association between ADRs related to DDIs and the presence of ATC (Anatomical Therapeutic Chemical) C medication during hospitalization and the length of hospital stay, in the multivariate analysis. CONCLUSION: Awareness of the most commonly occurring DDIs should be raised by the utilization of drug-drug interaction guides in the Romanian clinical practice which can help prescribers and pharmacists prevent DDI related ADRs.
Authors:
Camelia Bucşa; Andreea Farcaş; Irina Cazacu; Daniel Leucuta; Andrei Achimas-Cadariu; Cristina Mogosan; Marius Bojita
Related Documents :
21169796 - Prevalence of malignant hyperthermia and relationship with anesthetics in japan: data f...
23029066 - Recovered patients with stevens-johson syndrome and toxic epidermal necrolysis maintain...
23454676 - Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the ho...
832446 - Plasma l-alpha-acetylmethadol (laam) after acute and chronic administration.
6408666 - Influence of exteroceptive contextual conditions upon internal drug stimulus control.
16538186 - Assay for the simultaneous detection of the *1c and *1f alleles of the cyp1a2 gene by r...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-4
Journal Detail:
Title:  European journal of internal medicine     Volume:  -     ISSN:  1879-0828     ISO Abbreviation:  Eur. J. Intern. Med.     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9003220     Medline TA:  Eur J Intern Med     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
Affiliation:
University of Medicine and Pharmacy "Iuliu Hatieganu", Drug Information Research Center, Cluj-Napoca, Pasteur Street No. 6, 400349, Romania. Electronic address: cfarah@umfcluj.ro.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Met-genotype of the BDNF Val66Met polymorphism is associated with reduced Stroop interference in...
Next Document:  Effect of clustering of metabolic syndrome factors on capillary and cerebrovascular impairment.